Patrys Limited
ASX Code
PAB
Sector
Pharmaceuticals- Biotechnology & Life Sciences
Investor Centre
https://www.patrys.com/analysts-reports/
Website
https://www.patrys.com/
About
Patrys is a Melbourne based publicly-listed company on the Australian Securities Exchange (ASX:PAB). The company’s focus is the commercialisation of novel antibody therapeutics for oncology. Despite recent advances, new therapies are desperately needed to help fight a range of cancers. Patrys is committed to the development and commercialisation of novel antibody technologies and aims to revolutionise patient outcomes across a range of hard-to-treat cancers. Patrys is focussed on initially targeting underserved oncology indications, such as glioblastoma and metastatic triple-negative breast cancer, with the potential of expanding to other indications
News
| Patrys (ASX: PAB) - Webinar presentation |